These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10757596)

  • 41. 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study.
    Martin T; Baltas D; Kurek R; Röddiger S; Kontova M; Anagnostopoulos G; Dannenberg T; Buhleier T; Skazikis G; Tunn U; Zamboglou N
    Strahlenther Onkol; 2004 Apr; 180(4):225-32. PubMed ID: 15057433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urethra low-dose tunnels: validation of and class solution for generating urethra-sparing dose plans using inverse planning simulated annealing for prostate high-dose-rate brachytherapy.
    Cunha JA; Pouliot J; Weinberg V; Wang-Chesebro A; Roach M; Hsu IC
    Brachytherapy; 2012; 11(5):348-53. PubMed ID: 21937284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inverse automated treatment planning with and without individual optimization in interstitial permanent prostate brachytherapy with high- and low-activity 125I.
    Pinkawa M; Maurer U; Mulhern A; Gagel B; Block T; Borchers H; Grieger J; Henkel T; Eble M
    Strahlenther Onkol; 2003 Jun; 179(6):417-22. PubMed ID: 12789469
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of urinary catheterization on dosimetry after prostate implant brachytherapy with palladium-103 or iodine-125.
    Shirvani SM; Kudchadker RJ; Bruno TL; Likhacheva A; Swanson DA; Frank SJ
    Brachytherapy; 2011; 10(4):269-74. PubMed ID: 21296031
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interstitial rotating shield brachytherapy for prostate cancer.
    Adams QE; Xu J; Breitbach EK; Li X; Enger SA; Rockey WR; Kim Y; Wu X; Flynn RT
    Med Phys; 2014 May; 41(5):051703. PubMed ID: 24784369
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is there a role for postimplant dosimetry after real-time dynamic permanent prostate brachytherapy?
    Potters L; Calugaru E; Jassal A; Presser J
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1014-9. PubMed ID: 16682144
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A detailed examination of the difference between planned and treated margins in 125I permanent prostate brachytherapy.
    Patel AB; Waterman FM; Dicker AP
    Brachytherapy; 2003; 2(4):223-8. PubMed ID: 15062130
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with Hypofractionated External beam radiotherapy for localized prostate cancer: an analysis to determine the correlation between dose-volume histogram parameters in HDR brachytherapy and severity of toxicity.
    Ishiyama H; Kitano M; Satoh T; Kotani S; Uemae M; Matsumoto K; Okusa H; Tabata K; Baba S; Hayakawa K
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):23-8. PubMed ID: 19243900
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of interaction between number of implant catheters and dose-volume histograms in prostate high- dose-rate brachytherapy using a computer model.
    Charra-Brunaud C; Hsu IC; Weinberg V; Pouliot J
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):586-91. PubMed ID: 12738336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loading technique comparison in permanent 125I prostate implants.
    Williams BV; Horton J; Lawyer A; Chapman J
    Med Dosim; 1999; 24(4):273-7. PubMed ID: 10643736
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical trials of a urethral dose measurement system in brachytherapy using scintillation detectors.
    Suchowerska N; Jackson M; Lambert J; Yin YB; Hruby G; McKenzie DR
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):609-15. PubMed ID: 21093172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of dosimetric and biologic effective dose parameters for prostate and urethra using 131 Cs and 125 I for prostate permanent implant brachytherapy.
    Sahgal A; Jabbari S; Chen J; Pickett B; Roach M; Weinberg V; Hsu IC; Pouliot J
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):247-54. PubMed ID: 18722275
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dosimetric comparison of interactive planned and dynamic dose calculated prostate seed brachytherapy.
    Meijer GJ; van den Berg HA; Hurkmans CW; Stijns PE; Weterings JH
    Radiother Oncol; 2006 Sep; 80(3):378-84. PubMed ID: 16930753
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anatomy-based inverse optimization in high-dose-rate brachytherapy combined with hypofractionated external beam radiotherapy for localized prostate cancer: comparison of incidence of acute genitourinary toxicity between anatomy-based inverse optimization and geometric optimization.
    Akimoto T; Katoh H; Kitamoto Y; Shirai K; Shioya M; Nakano T
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1360-6. PubMed ID: 16406395
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dosimetric impact of interfraction catheter movement in high-dose rate prostate brachytherapy.
    Foster W; Cunha JA; Hsu IC; Weinberg V; Krishnamurthy D; Pouliot J
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):85-90. PubMed ID: 20605353
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multi-atlas-based segmentation of prostatic urethra from planning CT imaging to quantify dose distribution in prostate cancer radiotherapy.
    Acosta O; Mylona E; Le Dain M; Voisin C; Lizee T; Rigaud B; Lafond C; Gnep K; de Crevoisier R
    Radiother Oncol; 2017 Dec; 125(3):492-499. PubMed ID: 29031609
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MR and CT image fusion for postimplant analysis in permanent prostate seed implants.
    Polo A; Cattani F; Vavassori A; Origgi D; Villa G; Marsiglia H; Bellomi M; Tosi G; De Cobelli O; Orecchia R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1572-9. PubMed ID: 15590189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Simple diagrammatic method to delineate male urethra in prostate cancer radiotherapy: an MRI based approach.
    Kataria T; Gupta D; Goyal S; Bisht SS; Chaudhary R; Narang K; Banerjee S; Basu T; Abhishek A; Sambasivam S; Vishnu NT
    Br J Radiol; 2016 Dec; 89(1068):20160348. PubMed ID: 27748126
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CT-ultrasound fusion prostate brachytherapy: a dynamic dosimetry feedback and improvement method. A report of 54 consecutive cases.
    Fuller DB; Jin H; Koziol JA; Feng AC
    Brachytherapy; 2005; 4(3):207-16. PubMed ID: 16182221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.